Leukemia, Lymphoblastic, Acute Clinical Trial
Official title:
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
The purpose of this study is to show that myeloablative hematopoietic progenitor cell transplantation (HPCT) continues to offer acceptable disease-free survival for select patients requiring HPCT.
Myeloablative hematopoietic progenitor cell transplantation (HPCT) remains the standard of care for patients requiring HPCT. The purpose of this study is to evaluate the morbidity and mortality of myeloablative HPCT at Children's Memorial Hospital. It will also look to determine the toxicity of a single conditioning regimen consisting of total body irradiation (TBI), etoposide (VP-16), and Cyclophosphamide for patients with transplant eligible lymphoid malignant conditions or with transplant eligible myeloid malignant conditions who are receiving cord blood units, or to determine the toxicity of a single conditioning regimen consisting of Busulfan and Cyclophosphamide for patients with transplant eligible myeloid malignant conditions who are not receiving cord blood units. ;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00916045 -
Pilot Study of Unrelated Cord Blood Transplantation
|
Phase 2 | |
| Completed |
NCT00458250 -
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
|
Phase 1 | |
| Completed |
NCT02264873 -
Phase I, Dose Escalation Study of Decitabine
|
Phase 1 | |
| Recruiting |
NCT01015742 -
Unrelated Double Umbilical Cord Blood Units Transplantation
|
Phase 2/Phase 3 | |
| Completed |
NCT00475280 -
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
|
Phase 2 | |
| Recruiting |
NCT03331211 -
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia
|
N/A | |
| Terminated |
NCT01100658 -
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
|
N/A | |
| Completed |
NCT00241358 -
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT01976442 -
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
|
N/A | |
| Completed |
NCT00179764 -
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
|
N/A | |
| Terminated |
NCT01045382 -
MSC and HSC Coinfusion in Mismatched Minitransplants
|
Phase 2 | |
| Completed |
NCT00186901 -
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
|
Phase 3 | |
| Completed |
NCT00859586 -
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
|
N/A | |
| Terminated |
NCT00539656 -
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
|
Phase 1/Phase 2 | |
| Terminated |
NCT01186328 -
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
|
Phase 1 | |
| Terminated |
NCT01158885 -
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
|
Phase 2 | |
| Completed |
NCT02888990 -
Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia
|
Phase 2 | |
| Completed |
NCT03627208 -
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch
|
||
| Recruiting |
NCT03235973 -
Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes
|
Phase 1 |